NVAX Institutional Ownership
NOVAVAX INC
Latest close $7.70 as of Aug 5, 2026
Institutional Research
Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.
No institution has two comparable Schedule 13 observations yet.
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Beneficial ownership filing history
Showing 3 of 3 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 30, 2026 filed · 30d Initial Schedule 13G | Initial Schedule 13G | 8.3M | 12.00% | $8.14 | $7.93 | $7.70 |
| State Street CIK0000093751 | Dec 31, 2025 observed Feb 9, 2026 filed · 40d Initial Schedule 13G | Initial Schedule 13G | 9.5M | 12.00% | $6.72 | $8.70 | $7.70 |
| BlackRock Legacy CIK0001364742 | Dec 31, 2023 observed Jan 26, 2024 filed · 26d Schedule 13G amendment | Earliest Schedule 13G amendment found | 8.4M | 7.10% | $7.70 |
Related research
Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.